You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Nevi

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Optical Genome Mapping in Characterization of Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Bone Marrow samples collection
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Mar 15, 2023

Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)

Not yet recruiting
  • Multiple Myeloma
  • Plasma Cell Myeloma
  • Zirconium Zr 89-DFO-YS5
  • +3 more
  • San Francisco, California
    University of California, San Francisco
May 26, 2023

Infections Trial in Shanghai (SZEY-2108 for injetion, Placebo)

Recruiting
  • Infections
  • SZEY-2108 for injetion
  • Placebo
  • Shanghai, Shanghai, China
    Huashan Hospital Fudan University
Sep 24, 2023

Anemia Trial (UNIMMAP-MMS, IFA, Placebo)

Not yet recruiting
  • Anemia
  • UNIMMAP-MMS
  • +2 more
  • (no location specified)
Dec 27, 2022

Healthy Trial in Hangzhou (HSK36273, Placebo, Heparin sodium injection)

Completed
  • Healthy
  • Hangzhou, Zhejiang, China
    the Second Affiliated Hospital Zhejiang University School of Med
Feb 14, 2023

Atopic Dermatitis Trial in Glendale (NM26-2198, Placebo)

Recruiting
  • Atopic Dermatitis
  • NM26-2198
  • Placebo
  • Glendale, California
    California Clinical Trials Medical Group (CCTMG) managed by Pare
May 15, 2023

Analgesia Trial (Bupivacaine, Bupivacaine + Magnesium, Bupivacaine + Dexmedetomidine)

Not yet recruiting
  • Analgesia
  • (no location specified)
May 1, 2023

Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Köln, Germany
    Local Institution - 0017
Dec 4, 2023

Safety and Pharmacokinetic Trial in Barcelona (MBF-015 4 mg oral capsule, MBF-015 16 mg oral capsule, Placebo)

Completed
  • Safety and Pharmacokinetic
  • MBF-015 4 mg oral capsule
  • +2 more
  • Barcelona, Spain
    CIM-Sant Pau Institut de Recerca de l'Hospital de la Santa Creu
Sep 20, 2023

Atopic Dermatitis Trial (VC005, VC005 Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • (no location specified)
Aug 18, 2023

Arthritis, Gouty Trial in Shanghai (SSGJ-613, Placebo)

Not yet recruiting
  • Arthritis, Gouty
  • Shanghai, Shanghai, China
    Shanghai Xuhui District Central Hospital
Jul 20, 2023

Pain Trial in Daytona Beach (MEB-1170, Placebo)

Recruiting
  • Pain
  • Daytona Beach, Florida
    Labcorp Clinical Research Unit, Inc
Feb 17, 2023

Prostate Metabolism, Cancer Risk and Gut Microbiota

Recruiting
  • Prostate Cancer
  • Prostate Hyperplasia
  • MRI scan and laboratory visit
  • +4 more
  • Turku, Finland
  • +1 more
Oct 30, 2023

Insulin Resistance in Egyptian Patients With Multiple Sclerosis

Not yet recruiting
  • Multiple Sclerosis
  • Insulin Resistance
  • treatment of insulin resistance with appropriate modality according to each patient
  • (no location specified)
Aug 28, 2023

Relapsing Multiple Sclerosis, Multiple Sclerosis Trial (Placebo, Pirtobrutinib)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Multiple Sclerosis
  • (no location specified)
Oct 24, 2023

E.Coli Infections, Bloodstream Infection Trial in Cincinnati (SNIPR001, Placebo)

Active, not recruiting
  • E.Coli Infections
  • Bloodstream Infection
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology
Dec 1, 2022

Multiple Myeloma Trial (Teclistamab, Tocilizumab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 24, 2023

Duchenne Muscular Dystrophy, Exon 44 Trial in San Antonio (AOC 1044, Placebo)

Recruiting
  • Duchenne Muscular Dystrophy
  • Exon 44
  • AOC 1044
  • Placebo
  • San Antonio, Texas
    Worldwide Clinical Trials (Part A only)
Jan 2, 2023

Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

Recruiting
  • Relapse/Refractory Multiple Myeloma
  • DeepTag-GPRC5D Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

Heathy Participants Trial (AZD7053, Placebo)

Not yet recruiting
  • Heathy Participants
  • (no location specified)
Oct 19, 2023

Myotonic Dystrophy 1 Trial (ARO-DM1 for Injection, Placebo)

Not yet recruiting
  • Myotonic Dystrophy 1
  • ARO-DM1 for Injection
  • Placebo
  • (no location specified)
Nov 14, 2023

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • KYV-101 anti-CD19 CAR-T cell therapy
  • Standard lymphodepletion regimen
  • Palo Alto, California
    Stanford Multiple Sclerosis Center
Nov 13, 2023

Multiple Myeloma in Relapse Trial in Shenzhen (BCMA/GPRC5D double CAR-T)

Recruiting
  • Multiple Myeloma in Relapse
  • BCMA/GPRC5D double CAR-T
  • Shenzhen, Guangdong, China
    Shenzhen Qianhai Shekou Free Trade Zone Hospital
Sep 28, 2023

Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Worldwide (Ocrelizumab IV, Ocrelizumab SC,

Active, not recruiting
  • Relapsing Multiple Sclerosis
  • Primary Progressive Multiple Sclerosis
  • Ocrelizumab IV
  • +5 more
  • Tampa, Florida
  • +46 more
Jan 13, 2023